MNOV
MNOV
NASDAQ · Biotechnology

Medicinova Inc

$1.60
-0.02 (-1.23%)
As of Feb 8, 2:14 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 11.04M 11.56M 10.16M
Net Income -536,425 -578,623 -557,404
EPS
Profit Margin -4.9% -5.0% -5.5%
Rev Growth +9.7% -0.5% +16.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 32.67M 29.36M 29.97M
Total Equity 34.04M 33.10M 34.09M
D/E Ratio 0.96 0.89 0.88
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -810,707 -735,622 -650,086
Free Cash Flow -370,627 -351,629 -405,371